Abstract:Polycystic ovary syndrome (PCOS) is a heterogeneous disease defined by the presence of at least two of the following features: hyperandrogenism, oligoanovulation (OA), and polycystic ovarian morphology (PCOM). Hyperandrogenism is considered the cornerstone of PCOS. However, the most prevalent phenotype in Chinese women with PCOS is OA + PCOM [normo-androgenic PCOS (NA-PCOS)]. It has been reported that PCOS women have higher androgen levels in follicular fluid (FF), but whether NA-PCOS women have the same intrafollicular steroid profiles as hyperandrogenic PCOS (HA-PCOS) women has not been explored. In this study, we analyzed 17 steroids in stimulated size-matched ovarian follicles (16-18 mm) from 166 controls and 141 PCOS women [87 NA-PCOS and 54 HA-PCOS women, defined by a single serum testosterone (T) immunoassay measurement] using liquid chromatography tandem mass spectrometry, and investigated their relationship with baseline characteristics. No significant differences in intrafollicular steroid levels and product/ precursor ratios between NA-PCOS and HA-PCOS women were observed, though HA-PCOS women had significantly higher serum luteinizing hormone and T levels than NA-PCOS women. NA-PCOS and HA-PCOS women had significantly higher levels of androstenedione (AD), T and free androgen index, higher enzyme activity of P450c17 (AD/170H-progesterone), 3pHSD2 (170H-progesterone/170H-pregnenolone) and P450c11 (corticostemne/11-deoxycorticosterone), lower levels of pregnenolone, 170H-pregnenolone and 11-deoxycorticosterone, and decreased enzyme activity of P450aro (estrone/AD and estradiol/T) and 5 alpha-reductase (dihydrotestosterone/T) in FF than controls. NA-PCOS women had significantly higher intrafollicular cortisol levels and lower 11 beta H5D2 (cortisone/cortisol) activity than controls. Baseline serum T levels were slightly correlated with intrafollicular estrogens (E1: r = 0.192, p = 0.019; E2: r = 0.248, p = 0.002; E3: r = 0.248, p = 0.002) and androgens (DHEAS: r = 0.276, p = 0.001; AD: r = 0.185, p = 0.032; T: r = 0.173, p = 0.044) in controls and PCOS women respectively. Serum anti-Miillerian hormone (AMH) levels and antral follicle count (AFC) were correlated with intrafollicular cortisol (AMH: r = 0.380, p = 0.000; AFC: r = 0.177, p = 0.036) and corticosterone (AMH: r = 0.212, p = 0.048; AFC: r = 0.219, p = 0.009) levels in PCOS women. In conclusion, NA-PCOS and HA-PCOS women had statistically similar steroid metabolome profiles in FF, both of which showed a generally decreased steroidogenesis and hyperandrogenism compared to controls.

Analysis of serum anti-Müllerian hormone levels in the main phenotypes of polycystic ovary syndrome

Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?

Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators

Role of Anti-Müllerian Hormone and Testosterone in Follicular Growth: a Cross-Sectional Study.

Serum Anti-Müllerian Hormone and Insulin Resistance in the Main Phenotypes of Non-Obese Polycystic Ovarian Syndrome Women in China.

Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome

Association of Serum Anti-Mullerian Hormone and Free Testosterone with Different Phenotypes of Polycystic Ovary Syndrome

The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study

Anti-Müllerian Hormone Levels in Women with Polycystic Ovarian Syndrome Compared with Normal Women of Reproductive Age in China

Clinical predictive value of anti-Müllerian hormone and inhibin B in polycystic ovary syndrome

Relationship Between Anti-Müllerian Hormone and Polycystic Ovary Syndrome

Relationship Between Polymorphism of Anti-Mullerian Hormone,anti-Mullerian Hormone Receptor Type Ⅱ and Polycystic Ovary Syndrome

New insights into the relationship between Anti-Mullerian Hormone and Polycystic ovary syndrome and its diagnostic accuracy: An updated and extended meta-analysis using marginal beta-binomial model

The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome

Haplotype Analysis of Single Nucleotide Polymorphisms in Anti-Müllerian Hormone Gene in Chinese PCOS Women

Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome

Association of anti-Müllerian hormone and insulin resistance in adolescent girls with polycystic ovary syndrome

Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis

Usage of AMH as a determining test of fertility in women with polycystic ovary 2 syndrome (PCOS)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women